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K. M. Summers, K. S. Tam, J. W. Halliday, and L. W. PoweH
Department of Medicine, University of Queensland, Brisbane
Summary
The frequencies of different HLA-A and -B alleles in 77 Australian patients with hemochromatosis have
been compared with frequencies of HLA alleles not associated with hemochromatosis in 63 of their hetero-
zygous relatives and with published population frequencies. As for all other populations reported, an as-
sociation of HLA-A3 and HLA-B7 with the disease was found. A weak association with HLA-B12 was
also detected. No other significant positive or negative associations with HLA alleles were detected. In ad-
dition, HLA-A2 and -B12 were in significant linkage disequilibrium in patients but notin controls, which
may indicate a new mutation or recent recombination between HLA-A and hemochromatosis either in our
patient group or in the founding population. HLA-A1 and -B8 and HLA-A29 and -B12 were in linkage
disequilibrium in controls but not in patients, suggesting that this population is not segregating a
hemochromatosis allele on either of these haplotypes. Genetic linkage analysis using the program LIPED
showed strong linkage in 23/24 families, most of which had additional HLA alleles (other than A3 and
B7) associated with hemochromatosis. This provides evidence for a single hemochromatosis locus, possibly
with more than one allele.
Introduction
Hemochromatosis is an inherited disease which results
in a progressive accumulation of iron in the body, with
consequent damage to the liver, heart, and other or-
gans. This is presumably due to mutation in a gene or
genes involved in the maintenance of iron homeostasis,
although the precise function of this gene is not yet
known. The disease is inherited in autosomal recessive
fashion, with the disease locus apparently tightly linked
to the major histocompatibility complex coding for the
human leukocyte antigens (HLA) on chromosome 6
(Cartwright et al. 1979; Simon et al. 1979). Recent
population studies (Bassett et al. 1988; Edwards et al.
1988) have shown that the hemochromatosis allele is
one of the most common disease alleles in Europeans,
with a carrier frequency of about 1/10. Prevalence
figures have been summarized by Simon et al. (1988).
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Population studies have consistently shown strong
linkage disequilibrium between the hemochromatosis
allele and the HLA-A3 allele (Simon et al. 1987). There
is also a smaller disequilibrium between the hemochro-
matosis gene and HLA-B7 and, in some populations,
HLA-B14. The associations with the HLA-B alleles ap-
pear to be due to the disequilibrium between these and
HLA-A3, and the latter provides the only independent
marker of hemochromatosis (Simon et al. 1987). It is
not yet clear whether there are other low-frequency
alleles at the hemochromatosis locus in linkage dis-
equilibrium or equilibrium with different HLA-A alleles,
as has been seen for other common genetic diseases.
The prevalence of HLA antigens in hemochromatosis
patients in various populations has been presented by
Simon et al. (1988).
The present-day Australian population is largely Eu-
ropean in origin, with major migration since the 1940s
from the United Kingdom, Mediterranean countries,
and central Europe (Australian Bureau of Statistics
1986). Considerable founder effect might be expected
in the establishment of gene frequencies in this group.
Thus the population of Australia represents a unique
admixture of genes, different from the major founding
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populations (United Kingdom and Southern Europe)
and from the admixture found in other colonial groups
of European origin. The relatively short time since Eu-
ropean settlement (200 years, approximately 7 genera-
tions) would have minimized the effects of recent recom-
bination events, and associations between HLA alleles
and hemochromatosis might be expected to reflect the
relationships in the founding populations. We there-
fore considered that a study of HLA associations with
hemochromatosis in Australian families might help
show (a) whether there is one or more locus coding
for genes involved in iron homeostasis which, when mu-
tated, cause hemochromatosis and (b) whether there
may be more than one such mutant allele at this locus
(loci).
Subjects and Methods
Diagnosis of hemochromatosis was based on evidence
of increased mobilizable parenchymal iron stores as de-
tected by one or more of the following indications (Bas-
sett et al. 1986): stainable iron greater than grade 2
in the liver, hepatic iron concentration >60 imol/g dry
weight, hepatic iron index (hepatic iron concentra-
tion/age) >2 (Bassett et al. 1986), removal of >2.5 g
iron by repeated phlebotomy, and >2.2 mg iron excreted
in the 24 h following administration of 0.5 g desferri-
oxamine (Balcerzak et al. 1968). In all cases, other
known causes of iron overload (such as iron-loading
anemias) were excluded (Powell et al. 1980).
The study group included 77 hemochromatosis pa-
tients, from 52 families of European origin, who had
129 independent HLA-A and -B alleles. Where more
than one family member was affected, each indepen-
dent HLA haplotype associated with hemochromato-
sis was counted once only. Family studies showed that
at least 16 homozygous-heterozygous matings and two
possible homozygous-homozygous matings had oc-
curred. Ninety-eight of the HLA-A and -B alleles in pa-
tients could be assigned to definite haplotypes on the
basis of pedigree information; the remainder could not
be unequivocally assigned.
HLA alleles not shared with an affected family mem-
ber in heterozygous siblings, offspring, or parents of
a patient were considered not to be associated with
hemochromatosis. Seventy-four obligate heterozygotes
yielded 63 independent HLA-A and -B alleles. All het-
erozygous individuals were clinically asymptomatic,
and, where tested, none of the five indicators of disease
was positive, although some of these individuals had
raised serum ferritin or transferrin saturations. This con-
trol group differs from those in previous studies in that
it includes no hemochromatosis-associated HLA alleles.
Results were also compared with those for a blood-bank
control group (Baur and Danilovs 1980), among whom
approximately 10% will be carriers of one hemochro-
matosis allele and among whom 1/400 will be affected.
HLA typing was performed by standard methods by
the Immunology Laboratory at Princess Alexandra Hos-
pital, Brisbane, or by the Sydney Blood Transfusion Ser-
vice. Typing began in the 1970s, and certain antigen
subtypes were not recognized for some subjects. Thus
Bw44 was scored as B12, Bw5l as B5, Bw57 as B17,
Bw6O as Bw4O, and Bw62 as B15 in the combined
results. The subtypes were retained in the analysis of
families where appropriate.
Allele frequencies in the groups were compared using
the x2 contingency test without Yates's correction,
since the numbers are sufficiently large (Sokal and Rohlf
1969, p. 590). To allow for random associations de-
tected because of the large number of comparisons be-
ing made, probabilities were multiplied by the number
of comparisons, as indicated in the Results section.
Linkage disequilibrium between two loci was assessed
using the association Ar, calculated by the formula
quoted by Baur and Danilovs (1980):
(haplotype frequency) -
A_ (product of allele frequencies)
(frequency of locus 1 allele)
(1-frequency of locus 2 allele)
The significance of this association was determined
using the X2 contingency test. Linkage analysis was
carried out using the program LIPED supplied by Dr.
Jurg Ott, Columbia University, New York. For linkage
analysis, HLA haplotypes were coded according to the
suggestion of Ott (1978) to avoid problems due to large
numbers of different alleles and genotypes.
Results
HLA Alleles Associated with Hemochromatosis
In this Australian population of families with hemo-
chromatosis, the HLA-A3 antigen was detected in 48/77
(62%) of patients, and 13 of these were apparently
homozygous for the allele coding for this antigen, on
the basis of HLA typing and pedigree analysis. The
HLA-B7 antigen was found in 38/77 (49%) patients,
with eight apparently homozygous. Of these, five pa-
tients were typed as expressing only the A3 and B7 an-
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tigens (probable double homozygotes). A3 is found in
24% and B7 in 21% of the published controls (Baur
and Danilovs 1980).
Because extensive family data allowed us to distin-
guish between homozygosity and null alleles at the HLA-
A and -B loci, we were able to determine HLA allele
frequencies for our patient and heterozygous groups.
The 77 patients yielded 129 independent chromosomes
carrying a hemochromatosis gene. Table 1 gives the fre-
quencies of HLA-A and -B alleles that are found on
these chromosomes and that therefore are associated
with hemochromatosis in this population. Table 1 also
shows allele frequencies for the 63 nonhemochromatosis
haplotypes in heterozygous subjects with no evidence
of iron overload. These are compared with allele fre-
quencies in the published Australian Caucasian popu-
lation. The range of HLA-A and -B alleles was similar
in hemochromatosis and nonhemochromatosis haplo-
types, with only three alleles uniquely present in one
group or the other.
Frequencies of all HLA-A and -B alleles in hemo-
chromatosis and control groups were compared using
the X2 contingency test. Although a number of sig-
nificant results were initially seen, most of these could
Table I
HLA Alleles in Families with Hemochromatosis
BAUR AND DANILOVS
LINKED TO HEMOCHROMATOSIS NOT LINKED TO HEMOCHROMATOSIS (1980) FREQUENCIES
Uncorrected Corrected Uncorrected Corrected Uncorrected Corrected
Frequency Frequencya Frequency Frequencya Frequency Frequencya
ALLELE N (%) (%) N (%) (%) (%) (%)
Al ............. 18 13.9 23.4 10 15.8 19.2 18.6 21.4
A2 ............ 31 24.0 40.1 13 20.6 25.0 23.8 27.4
A3 ............ 53 41.1 ... 11 17.5 ... 13.1
...
All ............ 5 3.8 6.6 7 11.1 13.5 6.6 7.6
Aw23 ........... 0 0 0 2 3.2 3.8 2.4 2.8
Aw24 ........... 8 6.2 10.5 9 14.3 17.3 7.2 8.3
A25 ............ 1 .8 1.3 1 1.6 1.9 3.6 4.1
A26 ............ 2 1.6 2.6 1 1.6 1.9 3.0 3.4
A28 ............ 4 3.1 5.3 3 4.8 5.6 5.1 5.9
A29 ............ 2 1.6 2.6 5 7.9 9.6 4.5 5.2
Aw3O/w31 ...... 2 1.6 2.6 0 0 0 3.9 4.5
Aw32 ........... 3 2.3 3.9 1 1.6 1.9 4.2 4.8
Other ....... .... ... ... ... ... ... ... 4.4 5.1
B5 ............ 3 2.3 3.3 1 1.6 1.9 4.2 4.7
B7 ............ 40 31.0 ... 9 14.3 ... 11.1
B8 ............ 13 10.1 14.6 6 9.5 11.1 12.8 14.4
B12 ............ 27 20.9 30.3 12 19.0 22.2 13.3 15.0
B13 ............ 0 0 0 2 3.2 3.7 2.4 2.7
B14 ............ 6 4.7 6.7 3 4.8 5.6 6.0 6.7
B1S ............ 4 3.1 4.5 3 4.8 5.6 6.3 7.1
B17 ............ 9 7.0 10.1 6 9.5 11.1 4.8 5.4
B18 ............ 1 0.8 1.1 0 0 0 3.6 4.0
Bw22 ........... 1 0.8 1.1 1 1.6 1.9 3.6 4.0
B27 ............ 3 2.3 3.4 8 12.7 14.8 5.1 5.7
Bw35 ........... 11 8.5 12.4 6 9.5 11.1 6.3 7.1
B37 ............ 2 1.6 2.2 0 0 0 1.5 1.7
Bw38 ........... 2 1.6 2.2 0 0 0 1.5 1.7
Bw39 ........... 0 0 0 1 1.6 1.9 0.9 1.0
Bw4O ........... 6 4.7 6.7 4 6.3 7.4 9.1 10.2
Bw4l ........... 1 0.8 1.1 0 0 0 0.9 1.0
Bw49 ........... 0 0 0 1 1.6 1.9 1.5 1.7
Other . .. ... ... ... ... ... 5.9 6.6
a With the effects of A3 or B7 removed.
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be disregarded when allowance was made for the large
number of comparisons. This was done by multiplying
the probability of the x2 result by the number of com-
parisons. Three results remained significant when this
adjusted probability was examined. HLA-A3 and -B7
were higher in hemochromatosis patients than in the
published control group (X2 = 44.79 and 27.15,
respectively; Padjusted < .01). HLA-A3 was also higher
in patients than in the heterozygous control group (X2
= 10.63; Padjusted < .05), but the increase in HLA-B7
was not statistically significant (X2 = 6.22).
Simon et al. (1987) have shown that the increased
space taken by the A3 and B7 alleles can have the effect
of artificially decreasing the frequencies of other alleles,
which may mask frequency differences. Corrected fre-
quencies were calculated according to the procedure out-
lined by Simon et al. (1987) to examine this possibility,
and these frequencies are also shown in table 1. The
corrected frequency of HLA-B12 was apparently in-
creased compared with that in the published control
group (although it was not increased compared with
that in the heterozygous control group). This differ-
ence remained significant when the probability was ad-
justed for the number of comparisons (X2 = 10.72;
Padjusted < .05). There was no significant effect on the
corrected frequencies of HLA-A1, -All, -B14, or -Bw35.
Where pedigree analysis allowed the HLA-A and -B
alleles to be assigned to haplotypes, 42 different haplo-
types were seen in 98 independent chromosomes in pa-
tients (table 2). Twenty-two (22%) of these chromo-
somes carried the A3, B7 haplotype. There were 37
different haplotypes in the 63 nonhemochromatosis
Table 2
HLA Haplotypes in Families with Hemochromatosis
LINKED TO HEMOCHROMATOSIS NOT LINKED TO HEMOCHROMATOSIS
Uncorrected Corrected Uncorrected Corrected
Frequency Frequency' Frequency Frequencya
HAPLOTPYE N (%) (%) N (%) (%)
A3,B7 22 22.4 ... 5 7.9 ...
A2,B12 .......... 9 9.2 11.8 3 4.8 5.2
A3,Bw35 5 5.1 6.6 1 1.6 1.7
A1,B17 .......... 4 4.1 5.3 4 6.3 6.9
A3,B14 .......... 4 4.1 5.3 2 3.2 3.4
A3,B12 .......... 4 4.1 5.3 0 0 0
A1,B8 ........... 3 3.1 3.9 5 7.9 8.6
A2,B8 ........... 3 3.0 3.9 0 0 0
A2,B15 .......... 2 2.0 2.6 3 4.8 5.2
Aw24,B12 2 2.0 2.6 2 3.2 3.4
Aw24,Bw35 ...... 2 2.0 2.6 1 1.6 1.7
A1,B7 ........... 2 2.0 2.6 1 1.6 1.7
A1,B37 .......... 2 2.0 2.6 0 0 0
A1,B40 .......... 2 2.0 2.6 0 0 0
A2,B7 ........... 2 2.0 2.6 0 0 0
A3,BS ........... 2 2.0 2.6 0 0 0
A11,B27 ......... 2 2.0 2.6 0 0 0
A28,B12 ......... 2 2.0 2.6 0 0 0
A29,B12 ......... 1 1.0 1.3 5 7.9 8.6
A3,B27 .......... 1 1.0 1.3 2 3.2 3.4
Aw24,B27 1 1.0 1.3 2 3.2 3.4
A2,B40 1.......... 1.0 1.3 1 1.6 1.7
A11,Bw35 ........ 1 1.0 1.3 1 1.6 1.7
Aw24,B171........ 1.0 1.3 1 1.6 1.7
A2,B27 .......... 0 0 0 2 3.2 3.4
A11,B13 ......... 0 0 0 2 3.2 3.4
Aw24,B27 ........ 0 0 0 2 3.2 3.4
Othersb .......... 20 20.4 23.7 18 28.6 31.0
a With A3,B7 removed.
b Haplotypes that appeared once in only one category.
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chromosomes. Five (8%) of these 63 were A3,B7. This
difference in frequency of A3,B7 produced a x2 value
of 5.79, which is not significant when allowance is made
for the large number of comparisons (Padjusted v.4). No
other haplotype was different in patients compared with
controls when similarly adjusted probabilities were
used. As seen in table 3, A3 and B7 were in linkage
disequilibrium in patients and controls. It is interesting
that A2 and B12 were in disequilibrium in patients but
not in controls, while Al and B8, A3 and B14, and A29
and B12 were in disequilibrium in controls but not in
patients. Al and B17 were in negative equilibrium in
patients but in positive disequilibrium in controls, and
A3 and B12 were in negative disequilibrium in patients
but in linkage equilibrium in controls.
Linkage of HLA to Hemochromatosis
Linkage between the MHC and hemochromatosis
was analyzed in 24 families in whom complete HLA
typing of all key members was available or could be
deduced so that HLA type could be recoded by the
method of Ott (1978). The results of this analysis are
shown in table 4. All except one family showed posi-
tive linkage to HLA. Positive linkage was detected in
four families (8, 13, 21, and 23) in whom neither A3
nor B7 was found in any affected individual, in three
families (7, 10, and 20) in whom A3 but not B7 was
found, and in one family (24) with B7 but not A3. The
total LOD score for these families was 18.8 at a recom-
bination fraction in males and females of 2.1% (95%
confidence interval 0.4%-6%). When the female re-
Table 3
Linkage Disequilibrium for Frequent HLA Haplotypes
in Families with Hemochromatosis
LINKED TO NOT LINKED TO
HEMOCHROMATOSIS HEMOCHROMATOSIS
HAPLOTYPE N Ar X2 N Ar X2
A3,B7 ......... 22 .30 19.2 * * 5 .38 10.6**
A2,B12 ........ 9 .26 7.1 3 .08 .4
A3,Bw35 ...... 5 .03 .6 1 .03 0
A1,B17 ........ 4 -.56 9.1** 4 .31 12.8***
A3,B14 ........ 4 .05 2.8 2 .13 5.29X
A3,B12 ........ 4 -.13 5.82* 0 .20 .26
A1,B8 ......... 3 .13 2.25 5 .44 22.6
A29,B12 ....... 1 .03 1.1 5 .42 25.8***
*-.O1 < P < .05.
**t.OO1 < P < .01.
:':P < 001
combination fraction was set at the twice male recom-
bination fraction (Lalouel et al. 1985), a maximum LOD
score of 18.9 was achieved at a male recombination frac-
tion of 1.4% (95% confidence interval 0.3%-3.9%).
Three obligate recombinants were found, in families
14, 19, and 23. In family 19, a small nuclear family,
this resulted in negative linkage; but families 14 and
23 are large, multigeneration, extended pedigrees, and
positive linkage was detected. Two further recombinants
were found in the 28 families that could not be included
in the linkage analysis. These recombinants are dis-
cussed further by Powell et al. (1988).
An interesting result was obtained with family 18,
which consists of two affected brothers, who share no
haplotype, and the affected offspring of one of these,
who clearly show HLA linkage. A maximum LOD score
of 0.60 at a recombination fraction of zero was found.
The difference in the HLA types of the affected brothers
may result from a homozygote-homozygote mating or
from a homozygote-heterozygote mating with one
recombination, although the possibility of nonpater-
nity cannot be eliminated. This family has been dis-
cussed in detail by Powell et al. (1988).
Discussion
In this Australian population, as in all other popula-
tions ofpredominantly European origin that have been
studied, hemochromatosis is significantly associated
with HLA-A3 and -B7. While associations with Al, A11,
B14, Bw35, and Bw47 have been reported previously,
none of these antigens was found in increased frequency
in our population, even when frequencies were corrected
for effects of high values for A3 and B7. The corrected
frequencies of A2 and B12 in patients were marginally
increased over the frequency in heterozygous controls
and over the corrected published frequencies, with the
result for B12 compared with that for published con-
trols being significant at Padjusted < .05. No HLA-A or
-B allele was significantly depleted when frequencies
were corrected for the high frequency of A3 or B7. An
alternative control group from unpublished data of
T. J. Doran and H. V. Bashir (New South Wales Blood
Transfusion Service, Sydney) gave very similar results,
except that the increase in the corrected frequency of
B12 was no longer significant (X2 = 4.55).
Differences between the nonhemochromatosis con-
trol group presented here and the published frequen-
cies are probably attributable to the small size of our
group (N = 63). It might be expected that there would
be an increase in the hemochromatosis-associated al-
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Table 4
Linkage Between HLA and Hemochromatosis
HLA ALLELES LINKED TO
HEMOCHROMATOSIS
No. No.
FAMILY AFFECTED NOT AFFECTED' Omaxb LOD AT 0m.ix HLA-A HLA-B
1 ...... 4 5 0 1.81 3,11 7,27,w51
2 ...... 1 13 0 1.37 3 7,w5l
3 ...... 1 3 0 .13 3 7,18
4 ...... 1 3 0 .13 3 7
5 ...... 4 5 (2) 0 1.29 2,3,w24 7,8,12
6 ...... 3 4 0 1.20 2,3 7,12
7 ...... 2 2 (2) 0 .84 3,w30/w31 14,w35
8 ...... 3 1 (1) 0 .60 2,w24,28 w35,w44,w57
9 ...... 3 2(2) 0 1.40 3 7,w35
10 ...... 2 6 0 1.10 2,3 14,w44
11 ...... 1 6(1) 0 .62 3 7,w35
12 ...... 1 3(1) 0 .26 3 7
13 ...... 3 5 (1) 0 .98 2,w24 15,17
14 ...... 5 6 (1) .10 .78 1,3,w32 7,8,w35,w44,w60
15 ...... 7 7 (2) 0 2.29 1,2,3, 7,8,12,w35
16 ...... 2 6 0 1.10 3 1,40
17 ...... 1 3 (1) 0 .24 3,28 .7,12
18 ...... 4 2 0 .60 3,29,w32 7,8,12,w22
19 ...... 1 3 .50 0 1,3 7,w44
20 ...... 2 5 (2) 0 .80 2,3 14,w44
21 ...... 2 2(1) 0 .70 1,28 w44,w57
22 ...... 2 2 (2) 0 1.38 3,w24 7,17
23 ...... 4 11 .08 1.02 2,11 8,12,27
24 ...... 2 4 0 .85 2,w24 7,w44
a Numbers in parentheses are numbers of individuals who were not available for clinical assessment so that their hemochromatosis pheno-
type is unknown (although HLA types could be deduced from other family members).
b Recombination fraction that gives the maximum LOD score.
leles in the published frequencies compared with our
nonhemochromatosis controls (owing to the approxi-
mately 1/10 carrier frequency for the hemochromato-
sis allele). However, there is no evidence for this phe-
nomenon, perhaps again owing to the small size of our
heterozygous control population. Similarities between
our patient and heterozygote groups would indicate that
the population of hemochromatosis families is less het-
erogeneous with respect to HLA type than is the general
population from which the published frequencies are
drawn.
We also looked at haplotypic associations with hemo-
chromatosis and at patterns of linkage disequilibrium
and equilibrium in patients and controls. As in other
studies, we found that the only positive association was
with the HLA-A3,B7 haplotype, but in our group the
significance of the association disappeared when the
probability was corrected for the number of compari-
sons made. A larger sample size would be necessary
to demonstrate the magnitude of the association in our
population. HLA-A3,Bw35 is the most frequent marker
of hemochromatosis in northern Italy (Zacchi et al.
1982; Piperno et al. 1986) and shows marginally in-
creased frequency in our patient population, presum-
ably reflecting the major migration from Italy to Aus-
tralia in the past few decades (Castles 1988). The A3,B14
haplotype occurs at similar frequencies in patients and
controls, showing that this association, reported from
Brittany in France (Simon et al. 1988), is not present
in our patients. The haplotype HLA-A1,B8 is not in-
creased. This association has been reported in Sweden
(Ritter et al. 1984). Scandinavian groups have made
only a small contribution to the population in Australia.
Since the HLA-A1 and -B8 alleles are in strong linkage
disequilibrium in our controls but not in our patients,
it appears that a hemochromatosis allele associated with
46
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this haplotype has not been introduced into Australia.
In addition, the association of hemochromatosis with
the HLA-A1,B8 haplotype has not been found in Den-
mark (Milman et al. 1988), and it seems likely that
it represents a recent recombination or mutation event
which has not yet diffused beyond the localized region.
The strong linkage disequilibrium between A2 and
B12 in the patients may indicate that this population
is segregating a second hemochromatosis allele due to
mutation on a chromosome carrying this haplotype.
This result could also have been caused by a single
recombination event between HLA-A and the hemo-
chromatosis locus that introduced the hemochroma-
tosis allele on to an HLA-A2,B12 chromosome. A2 and
B12 are not in linkage disequilibrium in the control
group. The linkage of a hemochromatosis allele to the
A2,B12 haplotype probably occurred recently, as the
frequency of this chromosome has not yet increased
significantly in the patient group.
Analysis of linkage of hemochromatosis to the anti-
gens of the MHC showed positive genetic linkage in
23/24 families. Hemochromatosis genes linked to HLA-
A3 and those linked to other HLA-A types were clearly
allelic to each other, providing evidence for a single
hemochromatosis locus about 2 cM from the MHC.
Previous reports have given equivalent or slightly lower
recombination frequencies. Coding haplotypes as sin-
gle alleles tends to inflate the recombination fraction
if there are recombinants within the HLA region, but
this is unlikely to have had a large effect in our study.
Parents are fully informative in two of the three families
with obligate recombinants, and there is no evidence
for a recombination between HLA-A and -B. In the third
family, family 23, one parent was homozygous for A2
and B12, and the affected and unaffected haplotypes
could only be distinguished by DR type. The apparent
recombination could have occurred anywhere between
the HLA-DR locus and the hemochromatosis gene. The
recombination fraction is increased because of the results
for family 19. In this four-member nuclear family, an
affected female (age 18 years at diagnosis) has an HLA-
identical unaffected brother (age 24 years at most re-
cent examination). As discussed elsewhere (Powell et
al. 1988), it is possible that this male will develop the
disease and that use of an age-dependent penetrance
would reduce the impact of this family on the result.
Clearly, therefore, in at least 23 of these 24 families
hemochromatosis is HLA linked and disease genes car-
ried on HLA-A3,B7 chromosomes are allelic to those
on chromosomes with otherHLA haplotypes. This pro-
vides strong evidence that a single genetic locus is in-
volved in the majority of (probably all) cases of familial
hemochromatosis in Australia, although our results sug-
gest that there could be other disease-causing alleles
at this locus.
Simon et al. (1988) have suggested that a single, an-
cient mutation of a gene involved in iron homeostasis
resulted in the present-day hemochromatosis allele. This
mutation is thought to have occurred on a chromosome
carrying HLA-A3 and -B7. Over the years, recombina-
tion events between the HLA-A and -B loci have pre-
sumably led to the observed associations with other
HLA-B alleles on haplotypes carrying HLA-A3, and
recombinations between HLA-A and the hemochroma-
tosis locus have produced associations with other HLA-
A alleles and haplotypes. This original mutation should
be progressing toward equilibrium with the HLA al-
leles, although an association with HLA-A3 still remains
in all populations studied, including the present group,
either because there has been insufficient time to reach
equilibrium or because the association confers a selec-
tive advantage (Kushner et al. 1988). The recent muta-
tion or recombination event that has placed a hemo-
chromatosis allele on an HLA-A2,B12 chromosome
would have occurred in a population that has made a
major contribution to the present-day Australian gene
pool but that has contributed less to present-day Euro-
pean and other colonial populations. Price (1988) has
shown that the derivation of the present-day Australian
population is approximately 44% English, 17% Irish,
and 12% Scottish, with other European groups con-
tributing less than 4%. An origin in England or (in
view of the family names of many of our patients) Ire-
land thus seems likely for the linkage disequilibrium
ofHLA-A2 and -B12 in this group of hemochromatosis
patients. Conversely, HLA-A1 and -B8 are in tight link-
age disequilibrium in controls but not in patients, a
finding reflecting the low level of migration from Scan-
dinavia (where an association of hemochromatosis with
these HLA alleles exists) to Australia.
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